RNA, U4atac small nuclear 7, pseudogene (RNU4ATAC7P)

RNA, U4atac small nuclear 7, pseudogene (RNU4ATAC7P) is a noncoding RNA classified as a pseudogene of the U4atac small nuclear RNA (snRNA) family[1]. Pseudogenes are genomically derived from ancestral coding or noncoding RNA genes but lack the capability to encode functional products. RNU4ATAC7P does not produce a functional snRNA and has no established biological or therapeutic function. Its parent gene, RNU4ATAC, encodes the U4atac snRNA component of the minor spliceosome, with mutations in the parent gene linked to rare recessive developmental disorders (such as Taybi-Linder/MOPD1, Roifman and Lowry-Wood syndromes)[4], but there is no evidence implicating this pseudogene in human disease or drug response. In general, pseudogenes may exert regulatory roles through RNA-mediated mechanisms, such as acting as competitive endogenous RNAs or producing small interfering RNAs, but no such function has been characterized for RNU4ATAC7P specifically[5]. **Key points:** - This is not a therapeutic or drug target and has no known biomarker, mechanism, or disease association[1]. - As a pseudogene, this entry is often encountered in genomic data but typically lacks clinical or pharmacological relevance. - The canonical RNU4ATAC6P gene (not 7P) has established importance in splicing machinery and disease, which is distinct from this pseudogene[4]. **Technical notes:** - The entry is correct as a designation for a pseudogene, but is *not* a target for drug discovery or clinical biomarker analysis, so is_target should be marked false and is_incorrect true if the intention was to find an actionable target[1][4].

Other names

RNU4ATAC7PU4atac snRNA pseudogene 7RNA, U4atac small nuclear 7, pseudogene